Cyclophosphamide
Anemia, Hemolytic, Autoimmune
City of Hope Medical CenterSmall moleculePhase 2Active
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 95/ 100
Competitive context
10 Active assets in the Anemia, Hemolytic, Autoimmune cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
FILGRASTIM Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | Phase 2 | B |
PREDNISONE TABLETS City of Hope Medical Center | Phase 2 | CCC |
Ibrutinib Gruppo Italiano Malattie EMatologiche dell'Adulto | Phase 2 | CCC |
Acalabrutinib City of Hope Medical Center | Phase 2 | CCC |
Thiotepa University of Florida | Phase 1/2 | CCC |
View all 13 →
Same molecule, other indications
Cyclophosphamide is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →